These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 9739110

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
    Parker EM, Cubeddu LX.
    J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
    [Abstract] [Full Text] [Related]

  • 3. Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices.
    Fitzgerald JL, Reid JJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):313-23. PubMed ID: 8097569
    [Abstract] [Full Text] [Related]

  • 4. [3H]Dopamine release by d-amphetamine from striatal synaptosomes of reserpinized rats.
    Masuoka DT, Alcaraz AF, Schott HF.
    Biochem Pharmacol; 1982 Jun 01; 31(11):1969-74. PubMed ID: 7115417
    [Abstract] [Full Text] [Related]

  • 5. Different oxidative profile and nicotinic receptor interaction of amphetamine and 3,4-methylenedioxy-methamphetamine.
    Chipana C, García-Ratés S, Camarasa J, Pubill D, Escubedo E.
    Neurochem Int; 2008 Feb 01; 52(3):401-10. PubMed ID: 17716785
    [Abstract] [Full Text] [Related]

  • 6. Effects of (+)-fenfluramine on 3,4-methylenedioxymethamphetamine (MDMA) discrimination in rats.
    Baker LE, Makhay MM.
    Pharmacol Biochem Behav; 1996 Feb 01; 53(2):455-61. PubMed ID: 8808158
    [Abstract] [Full Text] [Related]

  • 7. Repeated exposure to MDMA and amphetamine: sensitization, cross-sensitization, and response to dopamine D₁- and D₂-like agonists.
    Bradbury S, Gittings D, Schenk S.
    Psychopharmacology (Berl); 2012 Oct 01; 223(4):389-99. PubMed ID: 22562523
    [Abstract] [Full Text] [Related]

  • 8. Comparison of (+)-methamphetamine, ±-methylenedioxymethamphetamine, (+)-amphetamine and ±-fenfluramine in rats on egocentric learning in the Cincinnati water maze.
    Vorhees CV, He E, Skelton MR, Graham DL, Schaefer TL, Grace CE, Braun AA, Amos-Kroohs R, Williams MT.
    Synapse; 2011 May 01; 65(5):368-78. PubMed ID: 20730798
    [Abstract] [Full Text] [Related]

  • 9. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
    Crespi D, Mennini T, Gobbi M.
    Br J Pharmacol; 1997 Aug 01; 121(8):1735-43. PubMed ID: 9283711
    [Abstract] [Full Text] [Related]

  • 10. Reserpine enhances amphetamine stereotypies without increasing amphetamine-induced changes in striatal dialysate dopamine.
    Callaway CW, Kuczenski R, Segal DS.
    Brain Res; 1989 Dec 25; 505(1):83-90. PubMed ID: 2611681
    [Abstract] [Full Text] [Related]

  • 11. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK, Nash JF, Gudelsky GA.
    J Pharmacol Exp Ther; 1995 Jun 25; 273(3):1063-70. PubMed ID: 7791076
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.